ConductScience.org, home

Paper39003018

Vaccine value profile for herpes simplex virus.

Johnston C and 12 others. Vaccine, 2024. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Vaccine value profile for herpes simplex virus. Papers, record 39003018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39003018

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vaccine value profile for herpes simplex virus.
PubMed
Journal
Vaccine
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
2.33, provisional
iCite
Revised in PubMed
2025-09-04
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Johnston CChristine
2Scheele SSuzanne
3Bachmann LLaura
4Boily MCMarie-Claude
5Chaiyakunapruk NNathorn
6Deal CCarolyn
7Delany-Moretlwe SSinead
8Lee SShaun
9Looker KKatharine
10Marshall CCaroline
11Mello MBMaeve B
12Ndowa FFrancis
13Gottlieb SSami

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Herpesvirus 2, HumanMajor topic
Herpes Simplex Virus VaccinesMajor topic
Herpes GenitalisMajor topic
Herpes SimplexMajor topic
Humans
Herpesvirus 1, Human
Vaccination

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
001World Health OrganizationInternationalPubMed
MR/X020258/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42499178A Decade of the Global STI Vaccine Roadmap: Progress, Gaps and Challenges.J Int AIDS Soc2026https://conductscience.org/library/papers/42499178PubMed
42234759Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis.Sci Adv2026https://conductscience.org/library/papers/42234759PubMed
42185525Mathematical modeling of the population-level impact of hypothetical herpes simplex virus type 2 curative therapy.Commun Med (Lond)2026https://conductscience.org/library/papers/42185525PubMed
41627575Herpes Simplex Virus Type 2 Screening in Persons with and Without HIV: Evidence, Challenges, and Future Directions.Curr HIV/AIDS Rep2026https://conductscience.org/library/papers/41627575PubMed
40825575Extracellular Vesicles Containing MDP Derived from Lactobacillus rhamnosus GG Inhibit HSV-2 Infection by Activating the NOD2-IFN-I Signalling Pathway.J Extracell Vesicles2025https://conductscience.org/library/papers/40825575PubMed
40630608Beyond behavioural change: prioritising structural solutions to control bacterial sexually transmitted infections.EClinicalMedicine2025https://conductscience.org/library/papers/40630608PubMed
40574945Neonatal herpes simplex virus infection combined with neonatal lupus erythematosus: a case reported.Front Pediatr2025https://conductscience.org/library/papers/40574945PubMed
40573903Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer's Disease, and the Potential Benefits of Targeted Treatment or Vaccination-A Virological Perspective.Vaccines (Basel)2025https://conductscience.org/library/papers/40573903PubMed
40463368Reverse vaccinology-based design of multivalent multiepitope mRNA vaccines targeting key viral proteins of Herpes Simplex Virus type-2.Front Immunol2025https://conductscience.org/library/papers/40463368PubMed
40207227
Therapeutic mucosal vaccination of herpes simplex virus type 2 infected guinea pigs with an adenovirus-based vaccine expressing the ribonucleotide reductase 2 and glycoprotein D induces local tissue-resident CD4+ and CD8+ TRM cells associated with protection against recurrent genital herpes.
Front Immunol2025https://conductscience.org/library/papers/40207227PubMed
40007004Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy.Viruses2025https://conductscience.org/library/papers/40007004PubMed
39338520Immunological Considerations for the Development of an Effective Herpes Vaccine.Microorganisms2024https://conductscience.org/library/papers/39338520PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39003018

GET https://conductscience.org/api/papers/v1/39003018/authors